Glass pipettes with measurement marks in a chemical analysis laboratory of the Ferrer company.

R & D

PIPELINE

Every molecule in our pipeline is a tangible manifestation of our commitment to social justice

Our pipeline reflects how we turn science into solutions with a real impact on people's lives. It is the result of a clear commitment to advance in areas with unmet medical needs, where we can make a significant difference.

Each of the programmes that make it up responds to a deep understanding of the disease and its environment, and advances thanks to collaboration with multiple actors in the healthcare ecosystem. Because behind every project there is the same ambition: that each scientific advance reaches those who need it and contributes to improving their quality of life.

PIPELINE

trastornos neurológicos
PNF 253 – Huntington's disease (HD)

Phase 3
trastornos neurológicos
FNP 254 – Amyotrophic Lateral Sclerosis (ALS)

Phase 3
trastornos neurológicos
FNP 223 – Progressive Supranuclear Palsy (PSP)

Phase 2
ENFERMEDADES PULMONARESVASCULARES E INTERSTICIALES
Inhaled Treprostinil**$ – Pulmonary Hypertension – Interstitial Lung Disease (PH-ILD)

Market
ENFERMEDADES PULMONARESVASCULARES E INTERSTICIALES
Inhaled treprostinil** – Idiopathic Pulmonary Fibrosis (IPF)

Phase 3
ENFERMEDADES PULMONARESVASCULARES E INTERSTICIALES
Inhaled treprostinil** – Progressive Pulmonary Fibrosis (PPF)

Phase 3
ENFERMEDADES PULMONARESVASCULARES E INTERSTICIALES
FNP 321# – Medical Device for Pulmonary Arterial Hypertension (PAH)

Market
ENFERMEDADES PULMONARESVASCULARES E INTERSTICIALES
FNP 221 – Medical Device for Pulmonary Hypertension – Interstitial Lung Disease (HP-EPI)

Registration

Commitment and animal welfare

Together with the scientific community, we work with the long-term commitment and aspiration to eliminate the use of animals in research and development programs. In this sense, we are committed to animal welfare in the following way:

Documents on animal welfare policy next to a pen and Ferrer's corporate tape for good.

We outsource to third-party providers

Animal studies included in our research and development programmes, requiring them to demonstrate compliance with animal welfare, in accordance with Directive 2010/63/EU as amended by Regulation (EU) 2019/2010, and to comply with applicable local and national laws.
Legal and regulatory studies

We only sponsor animal studies if there is a specific legal or regulatory requirement to do so, in order to make a health benefit claim.